Exercise to improve functional outcomes in persons with osteoporosis: a systematic review and meta-analysis A. VarahraI. B. RodriguesT. Birmingham Review 06 January 2018 Pages: 265 - 286
The effect of exercise on bone mineral density in adult cancer survivors: a systematic review and meta-analysis J. Dalla ViaR. M. DalyS. F. Fraser Review 02 October 2017 Pages: 287 - 303
Standards of reporting: the use of CONSORT PRO and CERT in individuals living with osteoporosis D. E. MackP. M. WilsonK. Brooks Review 02 October 2017 Pages: 305 - 313
Osteoporosis and bone mineral density in patients with Wilson’s disease: a systematic review and meta-analysis J. ChenbhanichC. ThongprayoonW. Cheungpasitporn Review 06 November 2017 Pages: 315 - 322
Abaloparatide-SC improves trabecular microarchitecture as assessed by trabecular bone score (TBS): a 24-week randomized clinical trial J. P. BilezikianG. HattersleyD. Hans Original Article Open access 22 November 2017 Pages: 323 - 328
The impact of GI events on persistence and adherence to osteoporosis treatment: 3-, 6-, and 12-month findings in the MUSIC-OS study A. ModiS. SenS. Sajjan Original Article Open access 06 November 2017 Pages: 329 - 337
Interaction between LRP5 and periostin gene polymorphisms on serum periostin levels and cortical bone microstructure J. PepeN. BonnetS. L. Ferrari Original Article 16 October 2017 Pages: 339 - 346
The effect of insulin on bone mineral density among women with type 2 diabetes: a SWAN Pharmacoepidemiology study K. RuppertJ. CauleyD. H. Solomon Original Article Open access 27 October 2017 Pages: 347 - 354
The role of previous falls in major osteoporotic fracture prediction in conjunction with FRAX in older Chinese men and women: the Mr. OS and Ms. OS cohort study in Hong Kong Y. SuJ. LeungT. Kwok Original Article 24 October 2017 Pages: 355 - 363
Older men who sustain a hip fracture experience greater declines in bone mineral density at the contralateral hip than non-fractured comparators A. M. RathbunJ. MagazinerM. C. Hochberg Original Article 24 October 2017 Pages: 365 - 373
Were VCF patients at higher risk of mortality following the 2009 publication of the vertebroplasty “sham” trials? K. L. OngD. P. BeallJ. A. Hirsch Original Article Open access 24 October 2017 Pages: 375 - 383
Milk and other dairy foods and risk of hip fracture in men and women D. FeskanichH. E. MeyerW. C. Willett Original Article 27 October 2017 Pages: 385 - 396
Comorbidities and medication use in patients with a recent clinical fracture at the Fracture Liaison Service L. VrankenC. E. WyersJ. P. Van den Bergh Original Article Open access 23 November 2017 Pages: 397 - 407
Characterization of trabecular bone microstructure in premenopausal women with distal radius fractures T. D. RozentalF. JohannesdottirM. L. Bouxsein Original Article 03 November 2017 Pages: 409 - 419
Serum parathyroid hormone is associated with increased cortical porosity of the inner transitional zone at the proximal femur in postmenopausal women: the Tromsø Study M. OsimaT. T. BorgenÅ. Bjørnerem Original Article 14 November 2017 Pages: 421 - 431
Two threshold levels of vitamin D and the prevalence of comorbidities in outpatients of a tertiary hospital I. N. FuruieM. J. J. MauroV. Z. C. Borba Original Article 15 November 2017 Pages: 433 - 440
The association between childhood fractures and adolescence bone outcomes: a population-based study, the Tromsø Study, Fit Futures T. ChristoffersenN. EmausL. A. Ahmed Original Article 16 November 2017 Pages: 441 - 450
Geisinger high-risk osteoporosis clinic (HiROC): 2013–2015 FLS performance analysis P. DunnD. WebbT. P. Olenginski Original Article 23 October 2017 Pages: 451 - 457
CT-based evaluation of volumetric bone density in fragility fractures of the pelvis—a matched case-control analysis D. SchönenbergR. GuggenbergerG. Osterhoff Original Article 13 November 2017 Pages: 459 - 465
Risk of venous thromboembolism among users of different anti-osteoporosis drugs: a population-based cohort analysis including over 200,000 participants from Spain and the UK E. Martín-MerinoI. PetersenD. Prieto-Alhambra Original Article 03 December 2017 Pages: 467 - 478
Defective WNT signaling associates with bone marrow fibrosis—a cross-sectional cohort study in a family with WNT1 osteoporosis R. E. MäkitieR. NiinimäkiO. Mäkitie Original Article 16 November 2017 Pages: 479 - 487
Spanish consensus on treat to target for osteoporosis X. NoguésJ. M. NollaL. Lizán Original Article Open access 24 November 2017 Pages: 489 - 499
Teriparatide for treatment of patients with bisphosphonate-associated atypical fracture of the femur S. L. GreenspanK. VujevichS. Perera Short Communication 30 October 2017 Pages: 501 - 506
A case of regional migratory osteoporosis J. SpieringsS. BoursH.R.M. Peeters Case Report Open access 24 October 2017 Pages: 507 - 510
Asfotase alfa treatment for 1 year in a 16 year-old male with severe childhood hypophosphatasia S. A. BowdenB. H. Adler Case Report 18 October 2017 Pages: 511 - 515
Worsening of soft tissue dystrophic calcification in an osteoporotic patient treated with teriparatide T. D. HtetJ. A. EismanJ. R. Center Case Report 15 December 2017 Pages: 517 - 518
Comments on Mignot et al.: bisphosphonate drug holidays in postmenopausal osteoporosis: effect on clinical fracture risk Markus Bredemeier Letter 27 November 2017 Pages: 519 - 519
Bisphosphonate drug holidays in postmenopausal osteoporosis: effect on clinical fracture risk. Response to comments by Bredemeier Julien PaccouBernard Cortet Letter 27 November 2017 Pages: 521 - 521
